A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent finding suggesting that Paxlovid is not effective for long Covid. A study by researchers at UC San Francisco suggests that an extended course of Paxlovid may benefit some patients suffering from long Covid, offering [...]from SciTechDaily https://ift.tt/3Jq9tDk
